AL
PDLI

AJO LP’s PDL BioPharma, Inc. PDLI Stock Holding History

AJO LP’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,173,883
Closed -$16M – 591
2015
Q3 		$16M Buy
3,173,883
+519,763
+20% +$2.98M 0.07% 186
2015
Q2 		$17.1M Buy
2,654,120
+644,240
+32% +$4.32M 0.07% 182
2015
Q1 		$14.1M Buy
2,009,880
+385,750
+24% +$2.79M 0.06% 196
2014
Q4 		$12.5M Sell
1,624,130
-13,260
-0.8% -$105K 0.05% 200
2014
Q3 		$12.2M Sell
1,637,390
-248,510
-13% -$2.31M 0.05% 176
2014
Q2 		$18.3M Sell
1,885,900
-170,600
-8% -$1.52M 0.08% 143
2014
Q1 		$17.1M Buy
2,056,500
+186,500
+10% +$1.6M 0.07% 147
2013
Q4 		$15.8M Sell
1,870,000
-189,100
-9% -$1.59M 0.07% 151
2013
Q3 		$16.4M Sell
2,059,100
-29,700
-1% -$239K 0.07% 144
2013
Q2 		$16.1M Buy
+2,088,800
New +$16.3M 0.08% 153

Other funds holding PDLI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AJO LP's PDLI Position: Q4 2015 in Review

AJO LP sold out of PDL BioPharma, Inc. (PDLI) in Q4 2015, closing a stake of 3,173,883 shares — an estimated $16M sold.

AJO LP first reported a position in PDLI in Q2 2013 and held it in 10 quarters. The position peaked at $18.3M in Q2 2014. 204 funds tracked by Wall St. Rank hold PDLI as of Q4 2015.

  • AJO LP reported no remaining PDL BioPharma, Inc. position as of Q4 2015 after selling out during the quarter.
  • AJO LP sold 3,173,883 PDL BioPharma, Inc. shares in Q4 2015, an estimated $16M.
  • AJO LP first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 10 quarters.
  • AJO LP's PDL BioPharma, Inc. position peaked at $18.3M in Q2 2014.
  • 204 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2015.

Based on AJO LP's 13F filing for Q4 2015, filed 11 Feb 2016.